ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Legal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,846Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 25

$552K Total Retail Price of All Prescriptions

Rank: 6 out of 25

287 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 287 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 7,431 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 35%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 414 344 1 1
LISINOPRIL 361 269 2 7
METOPROLOL TARTRATE 333 265 3 8
ATORVASTATIN CALCIUM 330 280 4 4
LEVOTHYROXINE SODIUM 295 180 5 5
FUROSEMIDE 254 234 6 3
WARFARIN SODIUM 242 212 7 12
AMLODIPINE BESYLATE 218 209 8 2
METOPROLOL SUCCINATE 201 190 9 9
GLIPIZIDE 167 145 10 42
OMEPRAZOLE 160 93 11 6
LANTUS 135 109 12 53
POTASSIUM CHLORIDE 132 114 13 29
NOVOLOG 116 101 14 73
CARVEDILOL 105 99 15 16
CITALOPRAM HBR 102 102 16 34
RISPERIDONE 99 93 17 50
HYDROCHLOROTHIAZIDE 96 58 18 18
OXYCODONE-ACETAMINOPHEN 95 78 S2 19 52
ISOSORBIDE MONONITRATE ER 92 79 20 57
TRAMADOL HCL 90 69 21 25
ALENDRONATE SODIUM 88 88 22 23
NAMENDA 87 87 23 32
ESCITALOPRAM OXALATE 87 79 23 38
CLOPIDOGREL 83 74 25 19
DONEPEZIL HCL 79 79 26 21
ENALAPRIL MALEATE 75 75 27 26
HUMULIN 70-30 74 70 28 119
PANTOPRAZOLE SODIUM 73 71 29 43
ALBUTEROL SULFATE 72 31 30 88
METFORMIN HCL 69 68 31 10
LACTULOSE 66 55 32 55
GABAPENTIN 66 51 32 37
LIPITOR 64 56 34 47
RAMIPRIL 64 52 34 30
ALLOPURINOL 63 63 36 97
SERTRALINE HCL 62 47 37 36
POLYETHYLENE GLYCOL 3350 58 53 38 140
IPRATROPIUM BROMIDE 58 32 38 140
LOSARTAN POTASSIUM 55 46 40 24
ZOLPIDEM TARTRATE 54 54 41 13
MIRTAZAPINE 53 53 42 33
ADVAIR DISKUS 52 42 43 27
GLIMEPIRIDE 52 48 43 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 27, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.